Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 16Phase NA 13Phase EARLY_PHASE1 6Phase 1/2 4Phase 3 3Phase 2/3 3

Status

Recruiting 50Active not recruiting 19Not yet recruiting 11Completed 5Suspended 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Agnosia 1Adenocarcinoma of Lung 1

Interventions

Radiotherapy 2Radiation 2Magnetic Resonance Spectroscopy 2Specimen Handling 1Platinum 1Oxycodone 1Nivolumab 1Ketorolac 1Ketamine 1Ipilimumab 1Cisplatin 1CTLA-4 Antigen 1Biopsy 1Acetaminophen 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Suspended × 30 days × Clear all
NCT05597878 2026-05-26

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Suspended
100 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

NCT04929041 2026-05-13

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

National Cancer Institute (NCI)

Phase 2/3 Suspended
427 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡